Goldman Sachs Group Inc. lessened its stake in Amdocs Limited (NASDAQ:DOX) by 27.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,623,960 shares of the technology company’s stock after selling 613,361 shares during the quarter. Goldman Sachs Group Inc. owned 1.13% of Amdocs worth $106,336,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Delpha Capital Management LLC acquired a new position in Amdocs in the 4th quarter worth about $109,000. Focused Wealth Management Inc acquired a new position in Amdocs in the 4th quarter worth about $157,000. American International Group Inc. acquired a new position in Amdocs in the 4th quarter worth about $199,000. CENTRAL TRUST Co increased its stake in Amdocs by 45.0% during the 4th quarter. CENTRAL TRUST Co now owns 3,388 shares of the technology company’s stock worth $222,000 after buying an additional 1,052 shares in the last quarter. Finally, Cerebellum GP LLC purchased a new stake in Amdocs during the 4th quarter worth approximately $246,000. 93.46% of the stock is owned by institutional investors and hedge funds.
Shares of Amdocs Limited (DOX) opened at $68.59 on Wednesday. The stock has a market capitalization of $9,887.58, a P/E ratio of 18.68, a PEG ratio of 2.35 and a beta of 0.55. Amdocs Limited has a 52-week low of $60.30 and a 52-week high of $71.37.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 20th. Stockholders of record on Friday, March 30th will be given a $0.25 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This is a positive change from Amdocs’s previous quarterly dividend of $0.22. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.46%. Amdocs’s dividend payout ratio is 28.39%.
Several research firms have commented on DOX. Stifel Nicolaus boosted their price objective on Amdocs from $72.00 to $75.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. BidaskClub lowered Amdocs from a “sell” rating to a “strong sell” rating in a research note on Tuesday, December 5th. Oppenheimer reiterated a “buy” rating and set a $77.00 price objective on shares of Amdocs in a research note on Wednesday, January 31st. ValuEngine upgraded Amdocs from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Finally, Zacks Investment Research lowered Amdocs from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $70.71.
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.